Invasive Hemodynamic for Congenital Heart Disease

This trial aims to gather data on adult congenital heart disease using invasive hemodynamic monitoring. This method helps researchers understand blood flow and provides important insights into heart conditions. The trial seeks participants who can consent, have a healthy weight (BMI of 30 or lower), normal blood pressure, and good kidney function. Participants should not have a history of heart disease, current orthopedic issues, or be taking heart medications. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to groundbreaking advancements in heart health.

If you are currently taking any heart-related medications, you cannot participate in this trial.

Research has shown that invasive heart monitoring is generally well-tolerated by patients, including those with complex congenital heart conditions. One study found that most patients did not experience major problems during this type of monitoring. Another study examined the CardioMEMS™ HF System, a specific device for monitoring heart function, and found it safe for tracking heart issues. However, adults with certain heart conditions, such as Fontan circulation, may experience higher rates of hospital visits and heart failure. This does not imply that the monitoring is unsafe, but it underscores the need for careful medical supervision. Overall, while invasive heart monitoring involves placing devices to closely observe the heart, current evidence suggests it is safe for most patients.¹²³⁴⁵

Researchers are excited about invasive hemodynamic techniques for managing heart conditions because these methods provide real-time, precise measurements of heart function. Unlike standard non-invasive methods, which often rely on indirect indicators, invasive hemodynamic monitoring gives direct insights into pressures within the heart chambers and major blood vessels. This detailed information can lead to more accurate diagnoses and tailored treatments, potentially improving outcomes for patients with complex heart conditions.

Research has shown that advanced techniques for monitoring blood flow and pressure inside the heart can greatly improve care for people with congenital heart disease (CHD). New treatments have extended the lives of these patients. This monitoring reduces the need for more invasive procedures, such as certain heart tests, especially for those with complex heart issues. It provides doctors with crucial information to better manage and treat heart problems. Overall, these advanced monitoring methods hold promise for improving CHD treatment by delivering more accurate and timely information.¹⁵⁶⁷⁸